A stern warning has been issued by the National Agency for Food and Drug Administration and Control (NAFDAC) to all stakeholders: comply with regulations or face the consequences. This bold statement sets the tone for a crucial conversation about ensuring public health and safety.
At a recent one-day sensitisation programme in Owerri, the South-East Zonal Director, Dr. Festus Ukadike, emphasized the importance of adhering to NAFDAC's regulatory provisions. The event brought together representatives from diverse sectors, including the National Association of Patent and Proprietary Medicines (NAPPMED), the Association of Table Water Producers (ATWAP), and many more.
Dr. Ukadike highlighted NAFDAC's commitment to safeguarding public health by ensuring that all regulatory products meet the highest standards of quality, safety, and efficacy. He stressed the shared responsibility of all stakeholders to protect public health and emphasized the role of NAFDAC as a regulatory body, guiding and enforcing compliance.
But here's where it gets controversial: the idea of a single drug curing multiple ailments, like hypertension, diabetes, or asthma, is scientifically questionable. Dr. Ukadike urged stakeholders to be vigilant and report any non-compliance with NAFDAC regulations. He advised them to always insist on NAFDAC registration numbers for any products, even for seemingly harmless items like snacks or fried plantains.
The zonal director also emphasized the importance of good hygiene and manufacturing practices, valid registration licenses, and maintaining personnel, procedures, and equipment in line with guidelines. He stressed the need for evidence-based clinical claims and proper storage and distribution practices.
And this is the part most people miss: the potential consequences of non-compliance. Dr. Ukadike expressed confidence that the sensitisation programme would improve compliance, but warned that NAFDAC would intensify enforcement actions against those involved in the production or sale of unsafe or unregistered products.
Earlier, the Imo State Coordinator, Mrs. Helen Okanya, explained that the meeting aimed to strengthen collaboration with sectoral groups to tackle substandard medical products, potable water issues, and poor hygiene practices. She emphasized the importance of collaboration in ensuring good storage practices and hygienic standards.
A pharmacist, Dr. Okey Unogu, commended NAFDAC for creating a platform to address the challenges faced by various groups. He acknowledged the importance of such initiatives in enhancing product registration, information sharing, and supply chain monitoring.
So, what are your thoughts on this matter? Do you think these regulations are necessary to protect public health, or do they impose unnecessary restrictions? Feel free to share your opinions and engage in a respectful discussion in the comments below!
